BackBlack Bird Biotech Overview

Black Bird Biotech Receivables

Black Bird Biotech's receivables is $1.6K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1553.00
↓ 60.31% YoYΔ $-2360.00 vs prior year quarter

Peer trimmed avg / median

Loading

Black Bird Biotech Receivables History

Loading

Black Bird Biotech vs. peers: Receivables Comparison

Loading

Black Bird Biotech Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Black Bird Biotech (BBBT) FAQ

As of the most recent data (September 2023), BBBT shows a receivables of $1.6K. That compares with $3.9K in the prior-year period — down 60.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BBBT's receivables is now $1.6K (was $3.9K) — a 60.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Black Bird Biotech is outperforming or lagging.

Tracking BBBT's receivables over time shows whether Black Bird Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $1.6K That compares with $3.9K in the prior-year period — down 60.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Black Bird Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.6K) with ownership activity and broader fundamentals.